Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients

Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients

Tumor biology plays a crucial role in the systemic treatment, specifically in HER2-positive tumors. Distinct biological behavior of breast cancer subtypes is associated with different rates of locoregional recurrence (LRR). HER2- positive breast cancer patients treated with surgery in combination wi...

Full description

Bibliographic Details
Main Authors: Iveta Kolarova, Bohuslav Melichar, Jaroslav Vanasek, Ales Ryska, Katerina Horackova, Jiri Petera, Milan Vosmik, Igor Sirak, Martin Dolezel
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2021-03-01
Series:Biomedical Papers
Subjects:
breast cancer
radiation therapy
her-2
locoregional recurrence
trastuzumab
Online Access:https://biomed.papers.upol.cz/artkey/bio-202101-0004_controversies-of-radiotherapy-in-human-epidermal-growth-factor-receptor-her-2-positive-breast-cancer-patients.php

Internet

https://biomed.papers.upol.cz/artkey/bio-202101-0004_controversies-of-radiotherapy-in-human-epidermal-growth-factor-receptor-her-2-positive-breast-cancer-patients.php

Similar Items